A Louisiana-founded pharmaceutical company trying to eradicate cancer in pets has secured a grant for a project it hopes will eventually help human patients.
Funding to Help Cancer Research for Dogs - Biz New Orleans bizneworleans.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizneworleans.com Daily Mail and Mail on Sunday newspapers.
The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early-stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.
An ingested liquid that delivers a small dose of carbon monoxide to the eye appears to target key factors that damage or destroy vision in both type 1 and 2 diabetes, scientists say.